SEVERE PERTUSSIS IN CHILDHOOD: UPDATE AND CONTROVERSY - SYSTEMATIC REVIEW
暂无分享,去创建一个
[1] F. Ramalho,et al. Severe pertussis infection , 2017, Medicine.
[2] M. Kazantzi,et al. Characteristics of Bordetella pertussis infection among infantsand children admitted to paediatric intensive care units in Greece: A multicentre, 11‐year study , 2017, Journal of paediatrics and child health.
[3] M. Zlamy. Rediscovering Pertussis , 2016, Front. Pediatr..
[4] P. Kilgore,et al. Pertussis: Microbiology, Disease, Treatment, and Prevention , 2016, Clinical Microbiology Reviews.
[5] N. Carbonetti,et al. Novel therapies for the treatment of pertussis disease. , 2015, Pathogens and disease.
[6] M. L. Penkal,et al. Resurgence of pertussis at the age of vaccination: clinical, epidemiological, and molecular aspects. , 2015, Jornal de pediatria.
[7] H. Marshall,et al. Predictors of Disease Severity in Children Hospitalized for Pertussis During an Epidemic , 2015, The Pediatric infectious disease journal.
[8] U. Heininger,et al. Antibiotic treatment of pertussis: are 7 days really sufficient? , 2015, The Pediatric infectious disease journal.
[9] D. Fisman,et al. Duration of Pertussis Immunity After DTaP Immunization: A Meta-analysis , 2015, Pediatrics.
[10] S. Amantéa,et al. Clinical, laboratorial and radiographic predictors of Bordetella pertussis infection☆ , 2014, Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo.
[11] A. Cruz,et al. Trends in hospitalizations and resource utilization for pediatric pertussis. , 2014, Hospital pediatrics.
[12] W. Schaffner,et al. Can we conquer coqueluche? , 2014, The Journal of infectious diseases.
[13] B. Feenstra,et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study , 2014, BMJ : British Medical Journal.
[14] T. Carvalhanas,et al. Serodiagnosis as Adjunct Assay for Pertussis Infection in São Paulo, Brazil , 2014, Clinical and Vaccine Immunology.
[15] M. Korppi. Whooping cough--still a challenge. , 2013, Jornal de pediatria.
[16] J. Cherry. Pertussis: Challenges Today and for the Future , 2013, PLoS pathogens.
[17] J. Cherry,et al. Exchange Blood Transfusion in the Management of Severe Pertussis in Young Infants , 2013, The Pediatric infectious disease journal.
[18] Carol E. Nicholson,et al. Critical Pertussis Illness in Children: A Multicenter Prospective Cohort Study* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[19] 何巍. 美国疾病预防控制中心(Centers for Diseases Control and Prevention,CDC):美国流感季节到来 , 2011 .
[20] K. Harrington,et al. Impact of Rapid Leukodepletion on the Outcome of Severe Clinical Pertussis in Young Infants , 2010, Pediatrics.
[21] H. Smaoui,et al. [Malignant pertussis: an underdiagnosed illness]. , 2010, Medecine tropicale : revue du Corps de sante colonial.
[22] R. Perera,et al. Symptomatic treatment of the cough in whooping cough. , 2010, The Cochrane database of systematic reviews.
[23] Nicholas Wood,et al. Pertussis: review of epidemiology, diagnosis, management and prevention. , 2008, Paediatric respiratory reviews.
[24] R. Holman,et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] S. Pelton,et al. Frequency of pertussis in children with prolongued cough , 2008, Scandinavian journal of infectious diseases.
[26] N. Curtis,et al. Antibiotics for whooping cough (pertussis). , 2007, The Cochrane database of systematic reviews.
[27] E. Segedin,et al. Pertussis requiring intensive care , 2007, Archives of Disease in Childhood.
[28] K. Edwards,et al. Leukopheresis therapy for severe infantile pertussis with myocardial and pulmonary failure , 2006, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[29] F. Muñoz. Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention. , 2006, Seminars in pediatric infectious diseases.
[30] T. Murphy,et al. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[31] Seema Mattoo,et al. Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies , 2005, Clinical Microbiology Reviews.
[32] M. J. Romano,et al. Pertussis pneumonia, hypoxemia, hyperleukocytosis, and pulmonary hypertension: improvement in oxygenation after a double volume exchange transfusion. , 2004, Pediatrics.
[33] J. Langley,et al. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. , 2004, Pediatrics.
[34] E. Elliott,et al. National study of infants hospitalized with pertussis in the acellular vaccine era , 2004, The Pediatric infectious disease journal.
[35] K. Edwards,et al. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? , 2003, Pediatrics.
[36] S. Halperin,et al. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. , 2003, The Journal of pediatrics.
[37] S. Mehra,et al. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. , 2001, The Pediatric infectious disease journal.
[38] C. Guzmán,et al. The virulence factors of Bordetella pertussis: a matter of control. , 2001, FEMS microbiology reviews.
[39] M. Loeffelholz,et al. Real-Time PCR Assay Targeting IS481of Bordetella pertussis and Molecular Basis for Detecting Bordetella holmesii , 2001, Journal of Clinical Microbiology.
[40] C. Locht. Molecular aspects of Bordetella pertussis pathogenesis. , 1999, International microbiology : the official journal of the Spanish Society for Microbiology.
[41] J. Cherry,et al. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. , 1997, Pediatrics.
[42] E. Korgenski,et al. Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States , 1997, Journal of clinical microbiology.
[43] F. Müller,et al. Laboratory diagnosis of pertussis: state of the art in 1997 , 1997, Journal of clinical microbiology.
[44] J. Langley,et al. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. , 1997, Pediatrics.
[45] I. Onorato,et al. Laboratory diagnosis of pertussis: the state of the art , 1987, The Pediatric infectious disease journal.
[46] J. W. Bass. Erythromycin for treatment and prevention of pertussis , 1986, Pediatric infectious disease.
[47] P. Gilligan,et al. Importance of culture in laboratory diagnosis of Bordetella pertussis infections , 1984, Journal of clinical microbiology.
[48] J. Regan,et al. Enrichment medium for the isolation of Bordetella , 1977, Journal of clinical microbiology.